Connecticut Post

Share

Connecticut Post

 •  August 9

NEW YORK (AP) — Mylan's second-quarter profit and revenue surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward because of "ongoing challenges and the uncertain U.S. regulatory environment." Shares tumbled 5 percent and were trading close to four-year lows at the opening bell...

Connecticut Post

 •  May 13

Edith Baker faced a devastating reality that patients with advanced cancer inevitably confront — radiation and chemotherapy could no longer contain her stage four bladder cancer. But there was a ray of hope. Baker’s oncologist at Saint Francis Hospital and Medical Center referred her to a clinical trial at UConn Health involving two immunotherapy...

Connecticut Post

 •  May 9

Nearly one out of every three drugs approved by the Food and Drug Administration have a new safety issue detected in the years after approval, according to a study led by Yale University researchers. According to a release from Yale, while most of the safety concerns are not serious enough to require withdrawal of a drug from the market, the...